| Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity D Shin, R Mukherjee, D Grewe, D Bojkova, K Baek, A Bhattacharya, ... Nature 587 (7835), 657-662, 2020 | 955 | 2020 |
| Proteomics of SARS-CoV-2-infected host cells reveals therapy targets D Bojkova, K Klann, B Koch, M Widera, D Krause, S Ciesek, J Cinatl, ... Nature 583 (7816), 469-472, 2020 | 918 | 2020 |
| Evidence of SARS-CoV-2 infection in returning travelers from Wuhan, China S Hoehl, H Rabenau, A Berger, M Kortenbusch, J Cinatl, D Bojkova, ... New England Journal of Medicine 382 (13), 1278-1280, 2020 | 770 | 2020 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 741 | 2021 |
| A lymphotoxin-driven pathway to hepatocellular carcinoma J Haybaeck, N Zeller, MJ Wolf, A Weber, U Wagner, MO Kurrer, J Bremer, ... Cancer cell 16 (4), 295-308, 2009 | 443 | 2009 |
| Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies A Wilhelm, M Widera, K Grikscheit, T Toptan, B Schenk, C Pallas, ... MedRxiv, 2021.12. 07.21267432, 2021 | 365 | 2021 |
| Detection of SARS-CoV-2 in raw and treated wastewater in Germany–suitability for COVID-19 surveillance and potential transmission risks S Westhaus, FA Weber, S Schiwy, V Linnemann, M Brinkmann, M Widera, ... Science of The Total Environment 751, 141750, 2021 | 364 | 2021 |
| The green tea polyphenol, epigallocatechin‐3‐gallate, inhibits hepatitis C virus entry S Ciesek, T von Hahn, CC Colpitts, LM Schang, M Friesland, J Steinmann, ... Hepatology 54 (6), 1947-1955, 2011 | 349 | 2011 |
| Next-generation sequencing of T and B cell receptor repertoires from COVID-19 patients showed signatures associated with severity of disease C Schultheiß, L Paschold, D Simnica, M Mohme, E Willscher, ... Immunity 53 (2), 442-455. e4, 2020 | 309 | 2020 |
| Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopes D Bankwitz, E Steinmann, J Bitzegeio, S Ciesek, M Friesland, E Herrmann, ... Journal of virology 84 (11), 5751-5763, 2010 | 276 | 2010 |
| SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes D Bojkova, JUG Wagner, M Shumliakivska, GS Aslan, U Saleem, ... Cardiovascular research 116 (14), 2207-2215, 2020 | 242 | 2020 |
| Interferon-α–induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection KA Stegmann, NK Björkström, H Veber, S Ciesek, P Riese, J Wiegand, ... Gastroenterology 138 (5), 1885-1897. e10, 2010 | 227 | 2010 |
| Growth factor receptor signaling inhibition prevents SARS-CoV-2 replication K Klann, D Bojkova, G Tascher, S Ciesek, C Münch, J Cinatl Molecular cell 80 (1), 164-174. e4, 2020 | 214 | 2020 |
| The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry G Gehring, K Rohrmann, N Atenchong, E Mittler, S Becker, F Dahlmann, ... Journal of Antimicrobial Chemotherapy 69 (8), 2123-2131, 2014 | 212 | 2014 |
| Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays N Kohmer, S Westhaus, C Rühl, S Ciesek, HF Rabenau Journal of Clinical Virology 129, 104480, 2020 | 203 | 2020 |
| Clinical performance of different SARS‐CoV‐2 IgG antibody tests N Kohmer, S Westhaus, C Rühl, S Ciesek, HF Rabenau Journal of Medical Virology 92 (10), 2243-2247, 2020 | 176 | 2020 |
| Omicron BA. 1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes J Quandt, A Muik, N Salisch, BG Lui, S Lutz, K Krüger, AK Wallisch, ... Science immunology 7 (75), eabq2427, 2022 | 164 | 2022 |
| The comparative clinical performance of four SARS-CoV-2 rapid antigen tests and their correlation to infectivity in vitro N Kohmer, T Toptan, C Pallas, O Karaca, A Pfeiffer, S Westhaus, ... Journal of clinical medicine 10 (2), 328, 2021 | 160 | 2021 |
| Lack of antiviral activity of darunavir against SARS-CoV-2 S De Meyer, D Bojkova, J Cinatl, E Van Damme, C Buyck, M Van Loock, ... International Journal of Infectious Diseases 97, 7-10, 2020 | 151 | 2020 |
| Cyclosporine A inhibits hepatitis C virus nonstructural protein 2 through cyclophilin A S Ciesek, E Steinmann, H Wedemeyer, MP Manns, J Neyts, N Tautz, ... Hepatology 50 (5), 1638-1645, 2009 | 151 | 2009 |
Heiner WedemeyerDept. oGastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School在 mh-hannover.de 的电子邮件经过验证
